ATE254625T1 - Eythromycinderivat mit antibiotischer aktvität - Google Patents

Eythromycinderivat mit antibiotischer aktvität

Info

Publication number
ATE254625T1
ATE254625T1 AT99941483T AT99941483T ATE254625T1 AT E254625 T1 ATE254625 T1 AT E254625T1 AT 99941483 T AT99941483 T AT 99941483T AT 99941483 T AT99941483 T AT 99941483T AT E254625 T1 ATE254625 T1 AT E254625T1
Authority
AT
Austria
Prior art keywords
derivative
antibiotic activity
eythromycin
preparation
discloses
Prior art date
Application number
AT99941483T
Other languages
English (en)
Inventor
Franco Pellacini
Daniela Botta
Stefano Romagnano
Enrico Albini
Domenico Ungheri
Giovanna Schioppacassi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE254625T1 publication Critical patent/ATE254625T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99941483T 1998-07-30 1999-07-27 Eythromycinderivat mit antibiotischer aktvität ATE254625T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI001775A IT1301967B1 (it) 1998-07-30 1998-07-30 Derivato di eritromicina ad attivita' antibiotica
PCT/EP1999/005484 WO2000006586A1 (en) 1998-07-30 1999-07-27 Erythromycin derivative with antibiotic activity

Publications (1)

Publication Number Publication Date
ATE254625T1 true ATE254625T1 (de) 2003-12-15

Family

ID=11380562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99941483T ATE254625T1 (de) 1998-07-30 1999-07-27 Eythromycinderivat mit antibiotischer aktvität

Country Status (8)

Country Link
US (1) US6583120B1 (de)
EP (1) EP1100806B1 (de)
AT (1) ATE254625T1 (de)
AU (1) AU5508399A (de)
DE (1) DE69912959T2 (de)
ES (1) ES2211149T3 (de)
IT (1) IT1301967B1 (de)
WO (1) WO2000006586A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica

Also Published As

Publication number Publication date
ITMI981775A1 (it) 2000-01-30
AU5508399A (en) 2000-02-21
DE69912959T2 (de) 2004-09-02
ES2211149T3 (es) 2004-07-01
EP1100806B1 (de) 2003-11-19
EP1100806A1 (de) 2001-05-23
US6583120B1 (en) 2003-06-24
ITMI981775A0 (it) 1998-07-30
DE69912959D1 (de) 2003-12-24
WO2000006586A1 (en) 2000-02-10
IT1301967B1 (it) 2000-07-20

Similar Documents

Publication Publication Date Title
NZ507221A (en) Antitumor agent
NO20014035L (no) System for oral administrasjon av medikament
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
IL166527A0 (en) Macrolide compounds endowed with antiinflammatory activity
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
NO2011025I1 (no) Telavancin, eller et farmasøytisk aksseptabelt salt derav, herunder inkludert telavancin hydroklorid
NO20034149D0 (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
HRP20000494B1 (en) Pharmaceutically active morpholinol
PT876388E (pt) Derivados de eritromicina triciclica
ATE261425T1 (de) Erythromycin-derivate mit antibiotischer wirkung
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
EP0816366A4 (de) Imidazothiazolverbindungen
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
DE69912959D1 (de) Eythromycinderivat mit antibiotischer aktvität
SE9803107D0 (sv) Novel Compunds
DK1086695T3 (da) Antivirale præparater omfattende yohimbin som aktivt princip
SE9803277D0 (sv) Novel compounds
HUP9801085A3 (en) Piperazinyl-alkyl-benzofurane derivatives, pharmaceutical compositions containing them as active ingredient and process for producing the active ingredient
DK1236726T3 (da) Triazaspiro[5.5]undecan-derivater og lægemidler indeholdende samme som den aktive bestanddel
ITMI20000972A0 (it) Formulazioni farmaceutiche, a rilascio modificato, con elevata biodisponibilita', contenenti principi attivi ad attivita' antibiotica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties